Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Pathol Oncol Res ; 21(1): 157-66, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24925218

ABSTRACT

Cervical cancer is a common and an important public health problem for adult women in developing countries. In contrast, cervical cancer incidence is low in Saudi Arabia. High-risk types of human papilloma viruses (HPV16 and HPV18) are the most significant risk factors for cervical cancer. HPV16/18-E6 oncoprotein is associated with HPV etiology, viral persistence and epithelial transformation. Cell cycle protein p16 INK4a (p16) plays an important role in the pathophysiology of cervical carcinomas. The aims of this study were to investigate the expression of HPV16/18-E6 and p16 in uterine cervical carcinomas in Qassim Region--Saudi Arabia, and to relate the results to the established clinicopathological prognostic parameters (age of the patient, educational level, birth control methods, number of pregnancy, smoking status, degree of histological differentiation, clinical stage, and lymph node metastasis) The study included 40 specimens of uterine cervical squamous cell carcinomas diagnosed and confirmed by biopsy. Histopathological classification of cervical tumors cases was performed according to the International Federation of Gynecology and Obstetrics (FIGO). Immunohistochemical analysis for HPV16/18-E6 and p16 were carried out on formalin-fixed paraffin-embedded sections of cervical tissues using avidin-biotin peroxidase method. There was a significant statistical correlation between HPV16/18-E6 expression in cervical carcinoma and nationality, smoking status and size of the tumor. HPV16/18-E6 oncoprotein expression in normal lymphocytes and endothelial cells in the tumor tissues and the adjacent normal cervical tissues suggest the possibility that HPV infection might spread to other organs through blood circulation. P16 expression has been correlated with high grade, stage of cervical SCC and HPV16/18-E6 expression. The current study supports the critical function of p16 and HPV16/18-E6 as specific markers for cervical carcinoma. However the potential for usage of p16 and HPV16/18-E6 as prognostic markers will require detailed follow data for a larger group of patients.


Subject(s)
Carcinoma, Squamous Cell/genetics , Cell Cycle/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , DNA-Binding Proteins/genetics , Oncogene Proteins, Viral/genetics , Repressor Proteins/genetics , Uterine Cervical Neoplasms/genetics , Adult , Aged , Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , Female , Human papillomavirus 16/metabolism , Human papillomavirus 18/metabolism , Humans , Middle Aged , Neoplasm Proteins/metabolism , Papillomavirus Infections/metabolism , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Prognosis , Retrospective Studies , Saudi Arabia , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology
2.
Saudi Pharm J ; 22(1): 33-7, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24493971

ABSTRACT

OBJECTIVE: To determine the effect of providing different formats about side effect information (verbal versus numerical) to acne patients in Saudi Arabia that are newly prescribed Roaccutane. DESIGN: A prospective study assessing patients' degree of estimation about side effect information. PARTICIPANTS: One hundred and forty-one acne patients newly prescribed Roaccutane. SETTINGS: Four dermatology clinics in Riyadh. Two in tertiary hospitals and the other two in private clinics. INTERVENTION: Each patient received information about two different side effects for Roaccutane. The side effect provided was supplemented with the probability of occurrence, which was written either in words or in numbers. (Dry eye "very common" or "30%"; Loss of hair "rare" or "0.01%"). MAIN OUTCOME MEASURES: Patient's estimation of side effect occurrence. Other outcomes were the likelihood of experiencing the side effect, the severity of the side effect, their perception of risk of the side effects to their general health, their satisfaction with the information provided and, whether the information provided will influence their decision to take the medicine. RESULT: The mean estimate for side effect occurrence for the dry eyes was 46% in the verbal group and 41% in the numerical group (p = 0.5); for loss of hair it was 50% in the verbal group and 39% in the numerical group (p = 0.03). There are no significant differences between verbal and numerical groups regarding the remaining measures. CONCLUSION: Patients overestimate the probability of occurrence of side effect. Verbal format of probability of occurrence is associated with higher estimation than the numerical format.

3.
Neurochem Res ; 31(10): 1171-80, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17043769

ABSTRACT

An increasing amount of evidence indicates that the disialoganglioside GD3 is involved in apoptosis in many cell lines. Our previous studies demonstrated that endogenous GD3 expression induced apoptosis in U-1242 MG glioma cells transfected with the GD3 synthase gene (U1242MG-GD3 cells). In this paper, we present further investigations on the molecular mechanisms of GD3-induced apoptosis in this cell line. We found that endogenously synthesized GD3 localizes to the caveolae of this cell line, where it promotes the localization of death receptor 5 (DR5), tumor necrosis factor receptor-1 (TNF-R1), and Fas (Apo-1) to the caveolae. In addition, caspase-8 was translocated to the caveolar fraction and cleaved; the cleaved proteins were then re-located into the high density fractions. However, GD3 had no effect on the distribution of the adapter protein Fas-associated death domain (FADD). We conclude that GD3 functions as a regulatory molecule early in the extrinsic apoptosis pathway.


Subject(s)
Apoptosis/physiology , Brain Neoplasms/pathology , Gangliosides/physiology , Glioma/pathology , Blotting, Western , Caspase 8/metabolism , Cell Line, Tumor , Humans
4.
J Neuropathol Exp Neurol ; 65(2): 152-61, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16462206

ABSTRACT

Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induces apoptosis in U-1242 MG cells. To investigate the molecular events involved in this process, we studied the effects of TRAIL on the localization within membrane fractions of molecules critical to the extrinsic apoptotic pathway. We report here that death receptor-5 (DR5), tumor necrosis factor receptor-1 (TNF-R1), and Fas receptor (FasR) are all located in the caveolin-1-enriched membrane fractions, and TRAIL caused the translocation of DR5, FasR, and TNF-R1 to the caveolar fractions. Caspase-8 is mainly located outside of caveolae, but TRAIL caused it to redistribute to the caveolin-1-enriched fractions where it was cleaved. Within 6 hours, the cleaved caspase-8 appeared in the high-density, noncaveolin fractions. Using confocal microscopy, we found that DR5, caspase-8, and caveolin-1 became progressively concentrated in blebs of plasmalemma as they formed in response to TRAIL. Our results provide the first evidence for the caveolar localization of TNF-R1 and DR5 and the coordinated redistribution among membrane fractions of several death receptors in response to TRAIL. We propose that the coordinated movement of these molecules among membrane compartments is probably an important component of the mechanisms regulating and initiating the extrinsic apoptotic pathway in human glioma cells.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Apoptosis/physiology , Glioma/metabolism , Membrane Glycoproteins/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Caspase 8 , Caspases/metabolism , Caveolae/chemistry , Caveolae/metabolism , Cell Fractionation , Cell Line, Tumor , Glioma/pathology , Humans , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor/metabolism , Receptors, Tumor Necrosis Factor, Type I/metabolism , TNF-Related Apoptosis-Inducing Ligand , fas Receptor/metabolism
5.
J Neurochem ; 96(5): 1301-14, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16441517

ABSTRACT

GD3 ganglioside induces apoptosis in several cell types, but the molecular events through which this occurs are largely unknown. We investigated the apoptotic effects of GD3 expression using U-1242 MG glioblastoma cells, as these cells synthesize almost exclusively GM3 and GM2 but not GD3. To express GD3 under the control of the TetOn system with minimum leakage, we modified the system by constructing a single tri-cistronic retrovirus vector containing three genes separated by two internal ribosome entry sites: (a) transcriptional silencer, tTS; (b) mutant of reverse transcriptional activator, rtTA2(S)-M2 (provided by H. Bujard, Heidelberg, Germany); and (c) enhanced green fluorescent protein (EGFP), as an indicator of the tri-cistronic gene expression. Using flow cytometry, we selected glioma cells (U1242MG-GD3 clone) that express high levels of GD3 in response to doxycycline. Expression of GD3 was associated with apoptosis as verified by annexin-V binding, TdT-mediated dUTPnick end-labelling assay (TUNEL), and EGFP degradation. GD3-induced apoptosis occurred via caspase-8 activation, as GD3 caused cleavage of caspase-8 and inhibition of caspase-8 activation by zlETD-fmk minimized GD3-induced apoptosis.


Subject(s)
Apoptosis/physiology , Gangliosides/physiology , Gene Expression Regulation, Neoplastic/physiology , Glioma/pathology , Alkaline Phosphatase/metabolism , Bacterial Proteins/physiology , Carrier Proteins/physiology , Caspase 8 , Caspases/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Chromatography, Thin Layer/methods , Dose-Response Relationship, Drug , Doxycycline/pharmacology , Flow Cytometry/methods , Gangliosides/metabolism , Gene Expression/drug effects , Gene Expression/physiology , Gene Expression Regulation, Neoplastic/drug effects , Glioma/metabolism , Green Fluorescent Proteins/metabolism , Humans , Immunohistochemistry/methods , In Situ Nick-End Labeling/methods , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Time Factors , Transfection/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...